Articles tagged with Menopause
Two promising neurokinin B antagonists, fezolinetant and elinzanetant, are being developed for the treatment of vasomotor symptoms, including hot flashes. Larger studies are necessary to confirm their benefits and risks. Hormone therapy remains the most effective treatment option for menopausal women.
A new study found that women diagnosed with type 1 diabetes at a younger age are more likely to experience early menopause. The research analyzed over 11,000 women and discovered an association between early diagnosis of type 1 diabetes and later age at natural menopause.
A study in C. elegans suggests that disrupting meiosis in reproductive cells accelerates aging and triggers a decline in healthspan, similar to humans. The research highlights the importance of reproductive fitness for overall health, with potential applications for early detection and treatment of age-related diseases.
A new study confirms that foot massage can help minimize menopause symptoms such as insomnia and hot flashes. By stimulating nerve cells in the legs, foot massage increases average daily sleep duration and reduces fatigue and anxiety levels.
A history of psychosocial stressors from childhood through pregnancy is associated with worse menopause symptoms and poorer well-being almost 2 decades later. Researchers found that physical abuse, sexual abuse, and financial instability were linked to increased symptoms.
A Rutgers study finds CBD improves glucose disposal, burns energy, and enhances bone density in estrogen-deficient mice. The compound also reduces inflammation and boosts beneficial gut bacteria.
A new study found that premenstrual mood symptoms are incredibly common worldwide, affecting over 64% of women. The most common symptoms reported were food cravings, mood swings or anxiety, and fatigue. The researchers hope to increase awareness and improve treatment options for women with premenstrual symptoms.
Recent evidence suggests hormone therapy at menopause does not significantly increase the risk of invasive breast cancer. However, estrogen combined with progesterone increases breast cancer risk for women with an intact uterus. Menopause experts offer reassurance to women and their healthcare providers about the safety of hormone ther...
A new study finds that women with menstrual cycles of fewer than 25 days during their reproductive years had a higher frequency of total menopause symptoms and an earlier age of natural menopause. Women with short menstrual cycles also experienced midlife sleep problems, heart discomfort, and depressive symptoms.
Scientists have found a potential link between follicle stimulating hormone (FSH) levels and postmenopausal obesity, which increases the risk of breast cancer. The study will analyze data from the Women's Health Initiative to understand the relationship between FSH and abdominal obesity.
A new study reveals that many perimenopausal women are using medical cannabis as an adjunct treatment for menopause-related symptoms, with the most common indications being sleep disturbances and mood/anxiety.
A study of over 1.4 million women found that premature menopause is associated with a higher risk of heart failure and atrial fibrillation. Women who experienced premature menopause had a 33% higher risk of heart failure and a 9% higher risk of atrial fibrillation compared to those without a history of premature menopause.
Middle-aged women are at increased risk of serious health outcomes due to weight gain. New guidelines recommend counseling healthy weight management for all middle-aged women.
The Women's Preventive Services Initiative issues guidelines for preventing obesity in midlife women, recommending counseling on healthy eating and physical activity. The guideline aims to mitigate concerns about weight stigma by normalizing counseling among all midlife women, regardless of BMI status.
A new study found an inverse association between breast cancer risk and n-3 PUFA consumption, especially in premenopausal women who are obese. Higher intake of marine n-3 PUFAs and total n-3 PUFAs was associated with a lower risk of breast cancer.
A new study published in Menopause finds that prasterone effectively improves urinary urge incontinence symptoms in women with genitourinary syndrome of menopause. This treatment option may offer relief for women experiencing pressure in the bladder, making it difficult to hold urine.
The North American Menopause Society has released its 2022 Hormone Therapy Position Statement, reaffirming the effectiveness of hormone therapy in treating hot flashes and other menopause symptoms. The updated statement also highlights its role in preventing bone loss and fractures.
A new study published in the Journal of Obstetrics and Gynecology found that having sex less often during menopause is not associated with an increased risk of developing sexual pain. Women who maintain or increase their sexual frequency do not appear to be at higher risk for developing sexual pain, according to the study.
A study published in Neurology found that postmenopausal women have more white matter hyperintensities than premenopausal women or men of the same age. Researchers also discovered that menopause accelerates the increase in brain biomarkers, which may be linked to an increased risk of stroke, Alzheimer's disease, and cognitive decline.
A study published in PLOS ONE found an association between reduced estrogen and progesterone levels and increased risk of snoring and obstructive sleep apnea in postmenopausal women. Low estrogen levels were linked to a 19% decreased odds of snoring, while low progesterone levels were associated with a 9% decrease.
Menopause is often perceived as a hormone deficiency, but experts argue this can lead to negative expectations. Instead, a more nuanced approach emphasizes the positive aspects of menopause, such as freedom from menstruation and reduced symptoms. Normalizing ageing and celebrating women's strengths can also improve experiences.
A University of Jyväskylä study found that menopausal women's ability to use fat as an energy source is not impaired by estrogen levels or menopause. Women who burned more fat during exercise had higher fitness and physical activity levels, while those with better glucose tolerance did not necessarily burn more fat.
A Phase 3 study found fezolinetant to significantly reduce the frequency and severity of moderate-to-severe vasomotor symptoms associated with menopause. The treatment also improved sleep disturbances, supporting its use for treating moderate-to-severe hot flashes.
The joint position statement from British Menopause Society, RCOG, and SfE provides evidence-based guidance for healthcare professionals caring for women experiencing menopause. It recommends an individualised approach to care, considering the risks and benefits of therapies as well as lifestyle choices.
A study of middle-aged women approaching menopause found increased body fat, particularly in the waist area, but those with healthier lifestyles had lower fat mass. The research suggests that maintaining physical activity and a balanced diet during this life stage may help protect against health risks associated with increased adiposity.
Women's metabolism alters during menopause due to changes in sex hormone levels. Metabolite profiles show increased lipid and cholesterol levels, especially triglycerides and LDL particles, which can lead to atherosclerosis.
A recent poll found that menopause symptoms significantly impact older women's sex lives, with 84% of women experiencing symptoms in the past year. Despite this, only 44% have discussed treatment with their healthcare provider, while 28% reported symptoms interfering with sexual activity.
Research published in the European Journal of Preventive Cardiology found that menopause is associated with a decline in cardiovascular health due to hormonal changes. Levels of bad cholesterol rise during menopause, and shifts in sex hormones are linked to this increase.
A recent study suggests that late menopause transition is associated with increased intensity of temporomandibular disorder-induced pain. The research found that TMD symptoms and menopause symptoms are primarily correlated during this stage, but decrease with age and progression through the postmenopausal phases.
A new study published in the Journal of the American Heart Association found that late menopause, occurring at age 55 or older, significantly increases heart failure risk among obese women. Obesity was a major contributing factor, with the risk being greatest among women who experienced late menopause.
Current guidelines for treating women's obesity, hypertension and diabetes are based on men's studies. Researchers call for sex-specific guidelines to accurately treat these conditions in women, as they have different risk factors and manifestations.
A study of 273,240 women found that life events influencing estrogen levels may be linked to a higher risk of dementia. Ever having been pregnant or having had an abortion was associated with a lower risk, while early or late menopause increased the risk.
A study published in PLOS Medicine found that certain reproductive events, such as shorter estrogen exposure, may be associated with increased dementia risk in women. However, the association between the number of children and dementia risk was similar for women and men, suggesting social and behavioral factors may play a role.
Researchers at UCLA found that premenopausal women with low levels of anti-Mullerian hormone are at a higher risk of experiencing significant bone loss within two to three years. The study suggests that measuring AMH levels could help physicians identify women at risk and provide targeted treatment.
A recent study suggests that eating nutrient-rich prunes every day may benefit bone health in postmenopausal women by reducing inflammatory factors. The research found significant reductions in inflammatory markers in prune-eating groups compared to a control group.
A new study suggests that working non-traditional shifts may delay the onset of natural menopause in women. The researchers found a significant association between rotating shifts and later age at menopause, possibly due to disruptions in circadian rhythms. Further investigation is necessary to determine the underlying mechanisms.
A new study by Chinese Academy of Sciences researchers identifies follicle-stimulating hormone (FSH) as the major pathogenic factor driving Alzheimer's disease in women. FSH increases during menopause and activates a critical pathway, leading to AD pathology.
A recent study suggests a significant association between sleep apnea and joint pain in postmenopausal women, with higher respiratory distress scores linked to joint pain severity. The researchers propose that detailed examination of sleep-disordered breathing be conducted in women with severe joint pain and fatigability.
A new study published in Menopause reveals that lifestyle interventions targeting metabolic changes are most valuable during perimenopause. The study found unfavorable body composition and metabolic characteristics beginning before the menopause transition, making it an opportune window for intervention.
Women who enter menopause before age 40 are more likely to develop dementia later in life compared to those who begin menopause at 50-51 years. Lowered estrogen levels may contribute to this increased risk, with strategies such as exercise and healthy lifestyle habits potentially reducing the risk of dementia.
A new study published in Menopause found that obesity and abdominal obesity significantly increase the risk of chronic obstructive pulmonary disease (COPD) and asthma in premenopausal and postmenopausal women. Maintaining a healthy body weight is key to preventing these conditions.
Researchers investigated the association between family history of breast cancer and mammographic breast density among 14,000 premenopausal women. The study found a positive correlation between having a family history of breast cancer and higher mammographic breast density in these women.
A new study finds that women who experienced their own abuse and witnessed the abuse of others have an earlier age of menopause. The research, published in Menopause, suggests that maternal childhood physical abuse and child sexual abuse accelerate maternal menopause timing by 8.78 years.
A new study found that more than half of postmenopausal women suffer from female pattern hair loss, a condition characterized by gradual thinning at the part line. The study also discovered a significant association between obesity and worsening hair loss in postmenopausal women.
Research published in BMJ Open found that older women with higher oestrogen levels had a lower risk of severe COVID-19 infection and death. Women taking hormone replacement therapy also showed a significantly reduced risk of dying from COVID-19, highlighting the potential benefits of hormonal treatment in reducing infection severity.
A new study has found a potential predictor for perimenopause in the form of IgG glycome composition, which may lead to improved diagnosis and treatment options. The study analyzed nearly 2000 women over 15 years and discovered changes in the IgG glycome that occur rapidly during menopause.
A UMass Amherst study found associations between oral contraceptive use and certain tubal ligation methods with lower levels of antimüllerian hormone (AMH), a biomarker for ovarian aging. This may suggest an increased risk for early menopause in women who have used oral contraceptives or undergone specific types of tubal ligation.
A new study reveals that bilateral oophorectomy may increase a woman's risk for dementia, with a 55% higher risk from age 65 years onward compared to men. Estrogen levels are suspected to play a key role in this association.
A new study suggests that music therapy can significantly decrease depression scores and help reduce menopause symptoms in postmenopausal women. This innovative approach has the potential to be used as a nonpharmacologic therapeutic option for managing menopause symptoms, particularly mood symptoms.
A new study found that resilience is linked to improved sexual health and overall well-being in menopausal women. Women with higher resilience scores had better quality of life during the menopause transition.
A new study published in Menopause journal reveals that severe depression and sexual dysfunction can impair a woman's cognitive skills, including orientation, registration, attention, recall, and language. The study suggests that these symptoms have a significant impact on women's overall cognitive performance.
A study found that arterial stiffness increases with age, but hormonal fluctuations also play a role. Women's hormone levels, particularly estradiol and follicle-stimulating hormone, were associated with stiffer arteries, while older women had stiffer vessels regardless of hormone status.
A new study found that hormonal changes during menopause lead to gastrointestinal problems such as indigestion, nausea, and bloating. The study suggests an association between race/ethnicity and menopause status with GI symptoms, with different racial/ethnic groups experiencing varying severities of symptoms.
A study of over 200,500 women found an increased risk of death in younger pre-menopausal women when ovaries and fallopian tubes were removed during surgery. In contrast, the procedure is safer for older post-menopausal women, whose ovaries have already stopped producing estrogen.
A study conducted at the University of Jyväskylä found that physically active lifestyle mitigates unfavourable changes in metabolic health during menopause. Menopausal transition is associated with increased abdominal fat mass, blood pressure, and blood glucose levels.
A new study found that hot flashes are less common in women with sarcopenia, and are positively associated with paraspinal muscle mass. The research highlights the need for further studies to understand the relationships between menopause symptoms, body composition, and aging.
A new study suggests that greater cumulative estrogen exposure in life may counter the brain-shrinking effect of menopause. Women with longer reproductive years, more children, and hormone therapy showed increased gray matter volume in certain brain areas. This protective effect may help reduce Alzheimer's risk in women.
A new study from the University of Eastern Finland found that postmenopausal women experience a significant decrease in bone mineral density, but at a lower rate than previously assumed. Women who received hormone replacement therapy and those with weight gain during follow-up showed minimal bone loss.
A new study found that women whose menstrual cycle length increased two years before menopause had better vascular health than those with stable cycles. Changes in cycle length may predict cardiovascular disease risk, allowing clinicians to recommend preventive strategies.
A new study using SWAN data suggests that changes in menstrual cycle length during the menopause transition can predict a woman's risk of developing atherosclerosis after menopause. Women with early increase trajectories had the worst cardiometabolic risk profile.